Clinical Trials Browser

Has results × trebananib × Tumor-Agnostic × Clear all

NCT02525536 2015-09-22

A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors

Phase 1 Completed

18 enrolled 38 charts

Neoplasms